Many times, we have written in this space about clinical trials of new medicines and how they are beneficial not only to patients, but also the economy and the advancement of science and patient care.
Most Recent Posts
Diabetes affects so many people in so many ways. PhRMA joined participants from around the area for a recent Step Out: Walk to Stop Diabetes event.
One of the most important aspects living with diabetes is adherence. When a diabetic fails to take care of themselves, an otherwise manageable disease can quickly turn into a hospital admission, or worse. As part of Diabetes Awareness Month and our focus on keeping people healthy, we have a guest blog post from policy analyst Nick McNeill from NEHI, a national health policy institute. He breaks down a new NEHI report about the link between adherence and hospital readmission rates.
We continue to focus on diabetes [visit the Medicines in Development for Diabetes resource center] with a guest post from Novo Nordisk's Ken Inchausti.
Being on top of anyone's list of the 'World's Most Innovative Companies' is a mighty fine set of bragging rights, and Apple can put another feather in its hat thanks to
Below is the latest guest post in our "Part D Perspectives" series, which we'll be hosting during the 2013 Medicare Part D Open Enrollment Period (Oct. 12 - Dec. 7).
Medicare Today's recent satisfaction survey tells us that Part D works. Ninety percent of seniors are satisfied with their coverage, and 96 percent say it works well.
A new infographic by Leon Farrant on Behance.net uses CDC data to explain how important vaccines are to multiple diseases, and visually explains the effects of a vaccine on